I'll call TGTX up from here. I loaded it for the January Effect. My entry is 3.69 average. What I like: Baker Brothers have large position. They will have a much anticipated ASCO presentation Their oncology compound makes them a take-out candidate for its combination therapy possibilities. No near-term financing risk